You have 9 free searches left this month | for more free features.

Condition

Non Small Cell Lung Cancer (1)

Non-small Cell Lung Cancer (NSCLC) (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Daiichi Sankyo Co., Ltd. (1)

Daiichi Sankyo, Inc. (1)

Collaborator

Intervention

ds-1205c (2)

gefitinib (1)

osimertinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

ds-1205c

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC (NSCLC) Trial in Taiwan (DS-1205c, Osimertinib)

Terminated

Non-small Cell Lung Cancer (NSCLC)

DS-1205c
Osimertinib

New Taipei City, Taiwan
+6 more

Jan 10, 2022

Non Small Cell Lung Cancer Trial in Japan (DS-1205c, Gefitinib)

Completed

Non Small Cell Lung Cancer

DS-1205c
Gefitinib

Chikusa, Aichi, Japan
+7 more

Jul 3, 2020